[script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-6169568552679962" crossorigin="anonymous"][/script]

Tag: Amyotrophic

Business

Denali Therapeutics’ Amyotrophic Lateral Sclerosis Misses Pivotal Trial, However Analyst Says It Was Anticipated – Denali Therapeutics (NASDAQ:DNLI)

January 7, 2025
admin

On Monday, Denali Therapeutics Inc. DNLI revealed topline outcomes from an evaluation of Routine G of the…